✦ LIBER ✦

901-22 Dual-Chamber Pacing for Patients with Hypertrophic Obstructive Cardiomyopathy: A Prospective Randomized, Double-Blind Crossover Trial

✍ Scribed by Rick A. Nishimura; Jane M. Trusty; David L. Hayes; Thomas G. Allison; David R. Holmes Jr; Sharonne N. Hayes; Raúl E. Espinosa; John D. Symanski; A. Jamil Tajik

Book ID: 119171150
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 132 KB
Volume: 25
Category: Article
ISSN: 1558-3597
DOI: 10.1016/0735-1097(95)91499-n

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dual-Chamber Pacing for Hypertrophic Car

Dual-Chamber Pacing for Hypertrophic Cardiomyopathy: A Randomized, Double-Blind, Crossover Trial

✍ Rick A Nishimura; Jane M Trusty; David L Hayes; Duane M Ilstrup; Dirk R Larson; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 274 KB

Analysis of dual-chamber pacing as a tre

Analysis of dual-chamber pacing as a treatment for refractory limiting symptoms in patients with obstructive hypertrophic cardiomyopathy

✍ Barry J. Maron 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 98 KB

A double-blind, randomized, crossover tr

A double-blind, randomized, crossover trial of dual chamber pacing with an “optimized” versus a nominal atrio-ventricular delay in symptomatic left ventricular dysfunction

✍ D.M. Gilligan; D.A. Sargent; M.A. Wood; K.A. Ellenbogen 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Comparison of dual-chamber pacing versus

Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: A comparison of objective hemodynamic and exercise end points

✍ Steve R Ommen; Rick A Nishimura; Ray W Squires; Hartzell V Schaff; Gordon K Dani 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Assessment of permanent dual-chamber pac

Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: Maron BJ, Nishimura RA, McKenna WJ, et al Circulation 99: 2927–2933, 1999

📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB